Evidence enhanced product labeling
-
Upload
ohdsi -
Category
Healthcare
-
view
124 -
download
2
description
Transcript of Evidence enhanced product labeling
![Page 1: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/1.jpg)
Evidence-Enhanced Product Labeling
(EPLs)
Jon DukeApril 15, 2014
![Page 2: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/2.jpg)
What Are We Trying to Solve?
A Problem with Labeling
• While considered the official source of drug safety information
– Labels are infrequently read by patient or providers
– The evidence for a given ADR is often scant
– They are one-size-fits-all and do not support personalized decision-making
![Page 3: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/3.jpg)
What Are We Trying to Solve?
A Problem with OHDSI
• While we are developing superb methods and brilliant tools to convey evidence on drug safety– Driving use of external tools requires significant
activation energy
– Awareness of the evidence being generated by OHDSI may diffuse slowly even to those who would be extremely interested (e.g., drug knowledge vendors)
– Users will generally need to know what they are looking for (e.g., what drug-outcome pairs)
![Page 4: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/4.jpg)
The EPL Big Picture
4
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
StructuredProduct Label
EnhancedProduct Label
![Page 5: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/5.jpg)
Evidence-Enhanced Product Labeling
• EPL is a platform for injecting approved product labeling with evidence from external sources
• Evidence may manifest as
– visual emphasis / de-emphasis of label content
– on-demand display of data and visualizations
• EPL is a trojan horse for getting people to see the incredible work of OHDSI while using a standard reference
![Page 6: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/6.jpg)
Enhanced Product Labeling:Framework vs App
• EPL is fundamentally a framework that can work with any web application
• Two Reference Apps
– Embedding of HOMER-like content within SPL (DOI_HOI evidence base)
– Embedding of PLATO-like content within SPL (requires mechanism to capture patient data-manual inputs, CCD, blue button, etc)
![Page 7: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/7.jpg)
JSLibrary
OHDSIAPIs
Other Evidence Sources
OHDSIKB
OHDSIPLATO
Services
SPL
![Page 8: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/8.jpg)
Potential OHDSI KB Content
![Page 9: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/9.jpg)
What’s in an SPL?Part 1: XML (the content)
9
XML/XSL/CSS HTML
![Page 10: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/10.jpg)
What’s in an SPL?Part 2: XSLT (the format)
10
![Page 11: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/11.jpg)
What’s in an SPL?Part 3: CSS (the style)
11
![Page 12: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/12.jpg)
What’s in an SPL?Roll them together HTML
12
![Page 13: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/13.jpg)
What’s in an SPL?HTML
13
![Page 14: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/14.jpg)
What’s in an SPL?HTML
14
![Page 15: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/15.jpg)
EPL Javascript
SPLXML/XSL/CSS HTML
EPL / OHDSIAPIs
Other Evidence Sources
OHDSIKB
OHDSIPLATO
Services
![Page 16: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/16.jpg)
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
Tell me all the known ADRs for this drug
From SPL to EPL
EPL / OHDSIAPIs
![Page 17: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/17.jpg)
EPL / OHDSIAPIs
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
From SPL to EPL
![Page 18: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/18.jpg)
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
![Page 19: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/19.jpg)
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
![Page 20: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/20.jpg)
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
![Page 21: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/21.jpg)
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
![Page 22: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/22.jpg)
Web App
EPL.js
Tell me the specific evidence for this HOIDOI_HOI_id=234515
Detail On-Demand
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
EPL / OHDSIAPIs
![Page 23: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/23.jpg)
EPL / OHDSIAPIs
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
From SPL to EPL
![Page 24: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/24.jpg)
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ns
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~Advanced Jquery Tooltips supportAJAX calls, visualzations, full HTML5
![Page 25: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/25.jpg)
Example EPL Prototype
25
![Page 26: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/26.jpg)
Example EPL Prototype
26
![Page 27: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/27.jpg)
Final Thoughts
• Evidence-enhancement not limited to SPLs, could be applied to SPCs or any other web content with identifiable drugs and outcomes
• Designed to be flexible in terms of novel evidence sources and presentation layers
• Will develop in parallel with OHDSI KB and APIs
27
![Page 28: Evidence enhanced product labeling](https://reader034.fdocuments.in/reader034/viewer/2022042816/559433b31a28aba11a8b4606/html5/thumbnails/28.jpg)
Thanks!
Questions?
28